Abstract submission is closed.

The International Biosimilar Congress Committee invites authors to submit abstracts for poster to be presented at the first of its kind event in the region in Biosimilars. This is a chance to scholars and researchers in the field of Biosimilars to showcase the findings of their research studies and study cases with pioneering experts coming from the region and other parts of the world.

Guidelines for submitting an abstract :

  • 28 March 2023

    Abstract Submissions Open (Poster/Oral)

  • 28 May 2023

    Abstracts Submissions Close (Poster/Oral)

  • 10 June 2023

    Author Notifications (Poster/Oral)

A special criterion for accepting abstracts will be their topic as well as structure, content and degree of innovation.

  • Please note that a maximum of 300 words is permitted. The titles and the names of the authors are excluded from this number and have to be entered separately. Tables should not be included in the abstract body.
  • Methods section should include type of statistical analysis done if applicable to the study.
  • Statements like “Results will be discussed” are not acceptable and may lead to a rejection of the abstract.

The scientific committee will accept abstracts based on their relevance and quality, structure, content and degree of innovation.

Abstract Topics :

  • Innovative Clinical Approach in Biosimilars
  • Biosimilars utilization worldwide
  • Updates in Biosimilars research
  • Challenges in Developing Biosimilars
  • Biosimilars in Inflammatory bowel disease
  • Biosimilars in Rheumatology
  • Biosimilars in Dermatology
  • Biosimilars in Oncology
  • Biosimilars in Hematology
  • Biosimilars in Hemato-Oncology

Structure of the Abstract for Poster Presentations

  • Background and Purpose
  • Methods
  • Results
  • Conclusions

Structure of the Abstract for Workshops

  • Authors
  • Workshop Title
  • Background
  • Aim
  • Session Description/Methodology
  • Estimated number of attendees
  • Keywords
  • Conclusion
  • Special request

Abstract Delivery Notification

Authors will be notified about the delivery of their abstract by e-mail immediately. In case you do not receive confirmation within 24 hours, please check your spam folder. In case of no confirmation e-mail, please contact: registration@internationalbiosimilarscongress.com

Author Agreement :

By submitting the abstract, the author confirms and agrees to the following:

  1. All authors approve submitting this work for presentation.
  2. The authors have done the work reported in the abstract and take full responsibility for the contents.
  3. The authors transfer all copyright ownership of the abstract to the IBC 2023.
  4. The authors agree to confine their presentation to information in the abstract.
  5. At least one author will be available to present the abstract if selected for the program.
  6. The author will immediately notify the IBC 2023 Scientific Committee if they are unable to make a presentation or if the presenting author must be changed.
  7. The authors guarantee that clinical studies and any animal tests have proceeded with the official permission from the proper authorities.
  8. All presenters will be responsible for their own registration fees, hotel and travel expenses. We regret that we cannot waive registration fees or cover expenses for any poster presenters.